NetworkNewsBreaks Archive - Page 1381 of 2081

ThursdayApr 23, 2020 2:16 pm

NetworkNewsBreaks – electroCore, Inc. (NASDAQ: ECOR) Provides Business Update, Introduces Select Guidance for Q1 2020

electroCore (NASDAQ: ECOR), a commercial stage bioelectronic medicine company, recently provided a business update and introduced select preliminary unaudited guidance for the first quarter of 2020. “As we and the rest of the world grapple with the humanitarian crisis and economic uncertainties brought on by the ongoing COVID-19 pandemic, we continue to advance toward our goal of making our gammaCore Sapphire(TM) non-invasive vagus nerve stimulation (‘nVNS’) technology available to the broadest possible patient population within our approved adult headache indications,” electroCore CEO Daniel Goldberger said in the news release. “We have taken significant steps, both operationally and financially, to sharpen…

ThursdayApr 23, 2020 2:10 pm

NetworkNewsBreaks – Sharing Services Global Corporation (SHRG) Appoints President Keith Hall as CEO of Elepreneurs, Elevacity Subsidiaries

Sharing Services Global Corporation (OTCQB: SHRG), formerly Sharing Services Inc., today announced that it has expanded the role of current President Keith Halls to include the title and responsibilities of CEO of the company’s two key operating subsidiaries, Elepreneurs U.S., LLC and Elevacity U.S., LLC, effective immediately. “We are pleased to make this announcement as Keith Halls is one of the most admired and effective leaders in the network marketing industry. He is going to lead an energetic and experienced corporate team at the perfect time to spearhead the expansion of our U.S. based operations as well as the addition…

ThursdayApr 23, 2020 1:11 pm

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) to Rely on Temporary Regulatory Filing Relief for Market Participants

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) today announced that it intends to rely on the temporary blanket relief for market participants from certain regulatory filings published by Canadian securities regulators on March 23, 2020, as a result of the COVID-19 pandemic. Per the update, the relief provides PowerBand Solutions with a 45-day extension to file its Financial Statements and Management's Discussion and Analysis ("MD&A") for the year ended December 31, 2019, as well as its financial statements and MD&A for the period ended March 31, 2020. The company expects to submit its annual filings on or before June…

ThursdayApr 23, 2020 1:02 pm

NetworkNewsBreaks – SinglePoint, Inc. (SING) Enters S-1 Registration Agreement to Raise up to $7M to Expand into New Markets

SinglePoint (OTCQB: SING) today announced the completion of an S-1 registration agreement to raise up to $7,000,000 with certain limitations on the amount of each sale, once the registration has been deemed effective. According to the update, the Equity Agreement, on a look-back basis and with no make-up provisions, is a true non-toxic equity investment. “This has been a long time in the making and filing an S-1 with a leading financial firm represents achieving another significant milestone for SinglePoint. Filling the Form-10, becoming a fully reporting issuer, and uplisting to the OTCQB were all integral and essential steps that…

ThursdayApr 23, 2020 12:29 pm

NetworkNewsBreaks – Energy Fuels Inc. (NYSE: UUUU) (TSX: EFR) Featured in Broadcast Highlighting U.S. Uranium Supply

Energy Fuels (NYSE: UUUU) (TSX: EFR) today announced the availability of a broadcast titled, “America’s National Security Blind Spot: Uranium and Rare Earth Element Production.” Few other companies have been more proactive or outspoken about supply chain risks than Energy Fuels. The Colorado-based company holds the title of the country’s largest producer of uranium and the leading conventional producer of vanadium—both designated as critical minerals by the U.S. government. A recent article authored by Greg Peel on Fnarena.com titled, “Uranium Week: Squeeze Is On” discusses the current demand for uranium while COVID-19 lockdowns continue. “Unlike the oil market, the uranium…

ThursdayApr 23, 2020 11:38 am

NetworkNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Announces Sharp Expansion in Production Capacity at the Farm

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that it has increased the total cannabis production capacity at NUGS Farm (the “Farm”) by 88% to 150% as a result of recent management decisions and production upgrades. According to the update, the company expects to produce between 1,500 pounds and 2,000 pounds of cannabis product over the next 45-60 days, and similar amounts of product over subsequent 45-60 day periods. “We have sharply expanded our production capacity to take advantage of an extremely advantageous context,” Cannabis Strategic Ventures CEO Simon Yu said in the…

ThursdayApr 23, 2020 10:19 am

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Commences Trading on the OTCQB Venture Market

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares have graduated from the OTC Pink Open Market to the OTCQB Venture Market (the “OTCQB”), a U.S. trading platform operated by the OTC Markets Group. Effective immediately, Champignon Brands will commence trading on the OTCQB under the ticker symbol “SHRMF.” Champignon’s common shares will continue to trade under the ticker symbol “SHRM” on the Canadian Securities Exchange as…

ThursdayApr 23, 2020 10:10 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Notice of Allowance for New Patent, Issuance of Stock Options Under Equity Incentive Plan

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its receipt of a Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for a new patent. According to the update, the new patent provides additional claims that protect the use of its DehydraTECH(TM) technology together with cannabinoids, nicotine, nonsteroidal anti-inflammatory drugs, or vitamins in mix and serve beverage formats. This patent, with application number 16/497,920 under the title "Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof," signifies another addition to Lexaria's first patent family, under…

ThursdayApr 23, 2020 9:21 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Executes Agreement to Exchange $2.1M Debt for Equity

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Wednesday announced that it has entered into an exchange agreement with POAI chief executive officer Dr. Carl Schwartz regarding a $2.1 million promissory note of the company. Per the agreement, Dr. Schwartz has exchanged the note for 1,533,481 shares of newly issued common stock at an exchange rate of $1.43 each, the closing price of the common stock on April 21, 2020. Dr. Schwartz agreed to not sell or transfer 766,740 shares (one-half of the shares) for three months after…

WednesdayApr 22, 2020 12:58 pm

NetworkNewsBreaks – Adaptimmune Therapeutics Inc. (NASDAQ: ADAP) Featured in Mizuho Securities Research Report

Adaptimmune Therapeutics Inc. (NASDAQ: ADAP) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We initiate shares of ADAP with a Neutral and a $3 price target. We see the efforts to develop a TCR-based treatment for solid tumors as having reached an important milestone of human data and a path forward for lead programs, but the valuation, in our view, reflects the near term value of ADAP's technology.” To request access to the full report, visit http://nnw.fm/SaZ9d About Adaptimmune Therapeutics Inc. Adaptimmune is a clinical-stage biopharmaceutical company focused on the development…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks